CURIS, INC. Stock-Based Compensation
CURIS, INC. (CRIS) reported Stock-Based Compensation of $1.14 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- CURIS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $569.00K, a 49.87% decline year-over-year.
- CURIS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $575.00K, a 50.60% decline year-over-year.
- CURIS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $795.00K, a 37.89% decline year-over-year.
- CURIS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $924.00K, a 33.24% decline year-over-year.
- CURIS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $4.02M, a 32.21% decline from fiscal 2024.
- CURIS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $5.93M, a 1.22% decline from fiscal 2023.
- CURIS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $6.00M, a 11.14% decline from fiscal 2022.
- CURIS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $6.75M, a 27.90% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $569.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.14M 10-Q · filed 2026-08-14 | $1.94M derived: sum of 3 quarters · filed 2026-08-14 | $2.86M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $575.00K 10-Q · filed 2026-05-13 | $1.37M derived: sum of 2 quarters · filed 2026-05-13 | $2.29M derived: sum of 3 quarters · filed 2026-05-13 | $3.43M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $795.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $1.72M derived: sum of 2 quarters · filed 2026-03-24 | $2.85M derived: sum of 3 quarters · filed 2026-08-14 | $4.02M 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | $924.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.06M derived: sum of 2 quarters · filed 2026-08-14 | $3.22M 10-Q · filed 2025-11-06 | $4.50M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $2.30M 10-Q · filed 2026-08-14 | $3.58M derived: sum of 3 quarters · filed 2026-08-14 | $4.96M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $1.16M 10-Q · filed 2026-05-13 | $2.44M derived: sum of 2 quarters · filed 2026-05-13 | $3.83M derived: sum of 3 quarters · filed 2026-05-13 | $5.53M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $2.66M derived: sum of 2 quarters · filed 2026-03-24 | $4.37M derived: sum of 3 quarters · filed 2026-03-24 | $5.93M 10-K · filed 2026-03-24 | ||||
| 2024-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.09M derived: sum of 2 quarters · filed 2025-11-06 | $4.65M 10-Q · filed 2025-11-06 | $6.20M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $3.26M 10-Q · filed 2025-08-05 | $4.81M derived: sum of 3 quarters · filed 2025-08-05 | $6.44M derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | $1.56M 10-Q · filed 2025-05-06 | $3.11M derived: sum of 2 quarters · filed 2025-05-06 | $4.74M derived: sum of 3 quarters · filed 2025-05-06 | $6.16M derived: sum of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.18M derived: sum of 2 quarters · filed 2025-03-31 | $4.61M derived: sum of 3 quarters · filed 2025-03-31 | $6.00M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $3.06M derived: sum of 2 quarters · filed 2024-11-14 | $4.45M 10-Q · filed 2024-11-14 | $6.20M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $2.82M 10-Q · filed 2024-08-01 | $4.56M derived: sum of 3 quarters · filed 2024-08-01 | $5.89M derived: sum of 4 quarters · filed 2024-08-01 | ||||
| 2023-03-31 | $1.40M 10-Q · filed 2024-05-07 | $3.14M derived: sum of 2 quarters · filed 2024-05-07 | $4.46M derived: sum of 3 quarters · filed 2024-05-07 | $6.43M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $3.07M derived: sum of 2 quarters · filed 2024-02-08 | $5.03M derived: sum of 3 quarters · filed 2024-02-08 | $6.75M 10-K · filed 2024-02-08 | ||||
| 2022-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $3.29M derived: sum of 2 quarters · filed 2023-11-02 | $5.01M 10-Q · filed 2023-11-02 | $6.45M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | $1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $3.68M 10-Q · filed 2023-08-03 | $5.13M derived: sum of 3 quarters · filed 2023-08-03 | $6.59M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $1.72M 10-Q · filed 2023-05-04 | $3.16M derived: sum of 2 quarters · filed 2023-05-04 | $4.62M derived: sum of 3 quarters · filed 2023-05-04 | $5.90M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $2.90M derived: sum of 2 quarters · filed 2023-03-13 | $4.18M derived: sum of 3 quarters · filed 2023-03-13 | $5.28M 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.74M derived: sum of 2 quarters · filed 2022-11-09 | $3.84M 10-Q · filed 2022-11-09 | $4.70M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.37M 10-Q · filed 2022-08-04 | $3.24M derived: sum of 3 quarters · filed 2022-08-04 | $3.86M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $1.10M 10-Q · filed 2022-05-05 | $1.96M derived: sum of 2 quarters · filed 2022-05-05 | $2.59M derived: sum of 3 quarters · filed 2022-05-05 | $3.17M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $865.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.49M derived: sum of 2 quarters · filed 2022-02-24 | $2.07M derived: sum of 3 quarters · filed 2022-02-24 | $2.70M 10-K · filed 2022-02-24 | ||||
| 2020-09-30 | $623.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.21M derived: sum of 2 quarters · filed 2021-11-09 | $1.83M 10-Q · filed 2021-11-09 | $2.52M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $585.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $1.21M 10-Q · filed 2021-08-03 | $1.90M derived: sum of 3 quarters · filed 2022-02-24 | $2.59M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $625.00K 10-Q · filed 2021-05-12 | $1.32M derived: sum of 2 quarters · filed 2022-02-24 | $2.00M derived: sum of 3 quarters · filed 2022-02-24 | $2.63M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $692.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.38M derived: sum of 2 quarters · filed 2022-02-24 | $2.01M derived: sum of 3 quarters · filed 2022-02-24 | $2.66M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $684.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $1.31M derived: sum of 2 quarters · filed 2020-11-10 | $1.97M 10-Q · filed 2020-11-10 | $2.60M derived: sum of 4 quarters · filed 2020-11-10 | ||||
| 2019-06-30 | $631.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $1.28M 10-Q · filed 2020-08-04 | $1.91M derived: sum of 3 quarters · filed 2020-08-04 | $2.81M derived: sum of 4 quarters · filed 2020-08-04 | ||||
| 2019-03-31 | $651.00K 10-Q · filed 2020-05-12 | $1.28M derived: sum of 2 quarters · filed 2020-05-12 | $2.18M derived: sum of 3 quarters · filed 2020-05-12 | $3.37M derived: sum of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | $631.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $1.52M derived: sum of 2 quarters · filed 2020-03-19 | $2.71M derived: sum of 3 quarters · filed 2020-03-19 | $3.94M 10-K · filed 2020-03-19 | ||||
| 2018-09-30 | $894.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $2.08M derived: sum of 2 quarters · filed 2019-11-05 | $3.31M 10-Q · filed 2019-11-05 | $4.69M derived: sum of 4 quarters · filed 2019-11-05 | ||||
| 2018-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $2.42M 10-Q · filed 2019-08-09 | $3.79M derived: sum of 3 quarters · filed 2019-08-09 | $5.09M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | $1.23M 10-Q · filed 2019-05-14 | $2.60M derived: sum of 2 quarters · filed 2019-05-14 | $3.90M derived: sum of 3 quarters · filed 2019-05-14 | $5.48M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $2.67M derived: sum of 2 quarters · filed 2019-03-26 | $4.26M derived: sum of 3 quarters · filed 2019-03-26 | $5.36M 10-K · filed 2019-03-26 | ||||
| 2017-09-30 | $1.29M 10-Q · filed 2017-11-07 | $2.88M derived: sum of 2 quarters · filed 2017-11-07 | $3.98M 10-Q · filed 2018-11-01 | $5.00M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2017-06-30 | $1.58M 10-Q · filed 2017-08-03 | $2.69M 10-Q · filed 2018-08-02 | $3.70M derived: sum of 3 quarters · filed 2018-05-03 | $5.33M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2017-03-31 | $1.10M 10-Q · filed 2018-05-03 | $2.12M derived: sum of 2 quarters · filed 2018-05-03 | $3.75M derived: sum of 3 quarters · filed 2018-05-03 | $4.66M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2016-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $2.64M derived: sum of 2 quarters · filed 2018-03-08 | $3.55M derived: sum of 3 quarters · filed 2018-03-08 | $4.33M 10-K · filed 2018-03-08 | ||||
| 2016-09-30 | $1.63M 10-Q · filed 2017-11-07 | $2.54M derived: sum of 2 quarters · filed 2017-11-07 | $3.31M 10-Q · filed 2017-11-07 | $4.31M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-06-30 | $908.00K 10-Q · filed 2017-08-03 | $1.68M 10-Q · filed 2017-08-03 | $2.68M derived: sum of 3 quarters · filed 2018-03-08 | $3.58M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-03-31 | $772.00K 10-Q · filed 2017-05-04 | $772.08K 10-Q · filed 2016-05-09 | $1.77M derived: sum of 2 quarters · filed 2018-03-08 | $2.67M derived: sum of 3 quarters · filed 2018-03-08 | $3.70M derived: sum of 4 quarters · filed 2018-03-08 | |||
| 2015-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $1.90M derived: sum of 2 quarters · filed 2018-03-08 | $2.92M derived: sum of 3 quarters · filed 2018-03-08 | $3.88M 10-K · filed 2018-03-08 | $3.88M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $901.00K 10-Q · filed 2016-11-03 | $900.88K 10-Q · filed 2015-11-09 | $1.92M derived: sum of 2 quarters · filed 2016-11-03 | $2.88M 10-Q · filed 2016-11-03 | $2.87M 10-Q · filed 2015-11-09 | $3.69M derived: sum of 4 quarters · filed 2017-03-09 | ||
| 2015-06-30 | $1.02M 10-Q · filed 2016-08-04 | $1.02M 10-Q · filed 2015-08-06 | $1.97M 10-Q · filed 2016-08-04 | $1.97M 10-Q · filed 2015-08-06 | $2.79M derived: sum of 3 quarters · filed 2017-03-09 | $3.61M derived: sum of 4 quarters · filed 2017-03-09 | ||
| 2015-03-31 | $951.10K 10-Q · filed 2016-05-09 | $1.77M derived: sum of 2 quarters · filed 2017-03-09 | $2.58M derived: sum of 3 quarters · filed 2017-03-09 | $3.27M derived: sum of 4 quarters · filed 2017-03-09 | ||||
| 2014-12-31 | $814.43K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $1.63M derived: sum of 2 quarters · filed 2017-03-09 | $2.32M derived: sum of 3 quarters · filed 2017-03-09 | $3.06M 10-K · filed 2017-03-09 | $3.06M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | $818.30K 10-Q · filed 2015-11-09 | $1.50M derived: sum of 2 quarters · filed 2015-11-09 | $2.25M 10-Q · filed 2015-11-09 | $2.75M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $683.82K 10-Q · filed 2015-08-06 | $1.43M 10-Q · filed 2015-08-06 | $1.93M derived: sum of 3 quarters · filed 2016-02-29 | $2.85M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $743.44K 10-Q · filed 2015-05-07 | $1.25M derived: sum of 2 quarters · filed 2016-02-29 | $2.17M derived: sum of 3 quarters · filed 2016-02-29 | $3.09M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $503.15K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.43M derived: sum of 2 quarters · filed 2016-02-29 | $2.34M derived: sum of 3 quarters · filed 2016-02-29 | $3.00M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $922.55K 10-Q · filed 2014-11-10 | $1.84M derived: sum of 2 quarters · filed 2014-11-10 | $2.50M 10-Q · filed 2014-11-10 | $3.28M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $915.97K 10-Q · filed 2014-08-07 | $1.58M 10-Q · filed 2014-08-07 | $2.36M derived: sum of 3 quarters · filed 2015-02-24 | $3.17M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $660.57K 10-Q · filed 2014-05-09 | $1.45M derived: sum of 2 quarters · filed 2015-02-24 | $2.25M derived: sum of 3 quarters · filed 2015-02-24 | $3.26M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | $785.60K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $1.59M derived: sum of 2 quarters · filed 2015-02-24 | $2.60M derived: sum of 3 quarters · filed 2015-02-24 | $3.62M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $807.89K 10-Q · filed 2013-11-12 | $1.82M derived: sum of 2 quarters · filed 2013-11-12 | $2.84M 10-Q · filed 2013-11-12 | $3.26M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $1.01M 10-Q · filed 2013-08-08 | $2.03M 10-Q · filed 2013-08-08 | $2.45M derived: sum of 3 quarters · filed 2014-03-13 | $2.76M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $1.02M 10-Q · filed 2013-05-09 | $1.44M derived: sum of 2 quarters · filed 2014-03-13 | $1.76M derived: sum of 3 quarters · filed 2014-03-13 | $2.12M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $420.61K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $732.55K derived: sum of 2 quarters · filed 2014-03-13 | $1.09M derived: sum of 3 quarters · filed 2014-03-13 | $1.77M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $311.94K 10-Q · filed 2012-11-06 | $673.79K derived: sum of 2 quarters · filed 2012-11-06 | $1.35M 10-Q · filed 2012-11-06 | $1.65M derived: sum of 4 quarters · filed 2013-03-13 | ||||
| 2011-06-30 | $361.85K 10-Q · filed 2012-08-09 | $1.04M 10-Q · filed 2012-08-09 | $1.34M derived: sum of 3 quarters · filed 2013-03-13 | $1.66M derived: sum of 4 quarters · filed 2013-03-13 | ||||
| 2011-03-31 | $677.71K 10-Q · filed 2012-05-10 | $980.77K derived: sum of 2 quarters · filed 2013-03-13 | $1.30M derived: sum of 3 quarters · filed 2013-03-13 | |||||
| 2010-12-31 | $303.06K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | $620.46K derived: sum of 2 quarters · filed 2013-03-13 | $1.97M 10-K · filed 2013-03-13 | |||||
| 2010-09-30 | $317.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $1.66M 10-Q · filed 2011-10-31 | ||||||
| 2010-06-30 | $1.35M 10-Q · filed 2011-08-04 | |||||||
| 2009-12-31 | $1.85M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |